![Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies - The Lancet Rheumatology Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/9040e79a-8349-4e30-befc-5445cb337b88/gr1_lrg.gif)
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies - The Lancet Rheumatology
![Pharmaceutics | Free Full-Text | Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency Pharmaceutics | Free Full-Text | Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-02668/article_deploy/html/images/pharmaceutics-14-02668-g001.png)
Pharmaceutics | Free Full-Text | Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency
![Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials: Molecular Therapy - Oncolytics Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/c818e3bc-861f-4902-9276-695534740008/fx1.jpg)
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials: Molecular Therapy - Oncolytics
![Pharmaceutics | Free Full-Text | Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency Pharmaceutics | Free Full-Text | Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-14-02668/article_deploy/html/images/pharmaceutics-14-02668-g009.png?1669809539)